Page 416 - Feline Cardiology

30

Drug Formulary

The following compilation of cardiovascular medica- It also is worth noting that no drug has ever been
tions has been obtained from published reports in origi- approved by the U.S. Food and Drug Administration
nal journal articles, conference proceedings, and for use in feline heart disease. Therefore, this listing
textbooks. Wherever possible, itemized reference cita- necessarily involves extralabel use, for which the
tions are given for rapid identification of source material prescribing veterinarian must assume responsibility
by readers wanting information in greater detail. This concerning treatment application/implementation,
index does not reflect original scientific research, and its adverse effects of administering or withholding treat-
compilers make no claims regarding efficacy, safety, or ment, owner-informed consent, and all other related
any other properties of drugs as listed here. Information issues.
concerning efficacy, safety, and other properties of these Abbreviations used in the index are as follows:
drugs is the domain of the original authors, reviewers, Cap = capsule; Ch = chewable tablet; CRI = constant
editors, or a combination of these, who investigated rate infusion; ER = extended release; H = human brand
and reported the data in the primary publications name; HM = human formulation; Inj = injectable;
from which this information is drawn, together with IM = intramuscular; IV = intravenous; Liq = oral
the responsibility of the prescribing veterinarian for liquid; OTC = over-the-counter (nonprescription);
ensuring that all reasonable resources are consulted PRN = as needed; SQ = subcutaneous; SR = sustained
prior to recommending, administering, or withholding release; Tab = tablet; V = veterinary brand name;
a medication. VM = veterinary formulation.

Feline Cardiology, First Edition. Etienne Côté, Kristin A. MacDonald, Kathryn M. Meurs, Meg M. Sleeper.
© 2011 John Wiley & Sons, Inc. Published 2011 by John Wiley & Sons, Inc.

441